Companies: 10,795·Total market cap: $144.5T
COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc.

CSCINASDAQHealthcare
$2.72
+$0.00(+0.00%)
Market Cap$8572175
P/E Ratio
52W High$4.6054
52W Low$1.75
Overview

COSCIENS Biopharma Inc. (CSCI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CSCI · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-6.21csci eps ttm · csci earnings per shareEarnings history
PE Ratio (TTM)csci pe ratio ttm · csci price to earningsPE Ratio deep dive
Revenue (TTM)$9.4Mcsci revenue ttm · csci annual revenueFull revenue history
Dividend YieldNo Dividenddoes csci pay dividends · csci dividend yieldDividend history
Shares Outstanding2.6Mcsci shares outstanding · csci floatShares outstanding history
Next EarningsTBAcsci earnings date · csci next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$13.8M▲ +92.96% YoY
202220232024
cosciens biopharma inc. revenue · csci revenue 2024
FY 2024Net Income-$15.3M▼ 339.28% YoY
202220232024
cosciens biopharma inc. net income · csci profit 2024
FY 2024EPS$-5.93▼ 213.76% YoY
202220232024
csci eps · cosciens biopharma inc. earnings per share 2024
TTM:Revenue: $9.4MNet Income: -$18.8MEPS: $-6.21View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+42.41%
3M+73.25%
YTD+32.04%
1Y-24.65%
5Y-54.67%

About COSCIENS Biopharma Inc.

CEOAnna Elizabeth Biehn
IPO DateJul 18, 1996
Employees40
CountryCA

COSCIENS Biopharma Inc. is a specialized biopharmaceutical company dedicated to the global development and commercialization of innovative therapeutic and diagnostic products. Its operations extend ac…

what is cosciens biopharma inc. · csci stock overview · cosciens biopharma inc. company profile · who is cosciens biopharma inc. ceo · csci NASDAQ · cosciens biopharma inc. headquarters · cosciens biopharma inc. business segments

About Stock Overview & Key Data

COSCIENS Biopharma Inc. (CSCI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 18, 1996. As of the latest trading session, CSCI stock price is $2.72, with a market capitalization of $8.6M. The stock has returned -24.65% over the past 12 months and +32.04% year-to-date.

In fiscal year 2024, COSCIENS Biopharma Inc. reported revenue of $13.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, COSCIENS Biopharma Inc. (CSCI) stock price is $2.72. The stock is traded on NASDAQ under the ticker symbol CSCI. The 52-week range is $1.75 – $4.61.

CSCI stock priceCSCI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice